Mochida Pharmaceutical Co (FRA:MFY) E10: €1.16 (As of Mar. 2026)


FRA:MFY Mochida Pharmaceutical Co Ltd FRA:MFY
71 GF Score
Price €16.70
GF Value €19.68
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co E10?

Mochida Pharmaceutical Co FRA:MFY 71 E10 is €1.16 as of Mar. 2026. GuruFocus rates FRA:MFY with a GF Score™ of 71/100 and a GF Value™ of €19.68. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.240. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Mochida Pharmaceutical Co's average E10 Growth Rate was 0.90% per year. During the past 3 years, the average E10 Growth Rate was -0.70% per year. During the past 5 years, the average E10 Growth Rate was -0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Mochida Pharmaceutical Co was 2.70% per year. The lowest was -0.90% per year. And the median was 0.15% per year.

As of today (2026-06-29), Mochida Pharmaceutical Co's current stock price is €16.70. Mochida Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was €1.16. Mochida Pharmaceutical Co's Shiller PE Ratio of today is 14.40.

During the past 13 years, the highest Shiller PE Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.72. And the median was 16.73.


Mochida Pharmaceutical Co  (FRA:MFY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mochida Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=16.70/1.16
=14.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.72. And the median was 16.73.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mochida Pharmaceutical Co E10 Related Terms


Mochida Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Mochida Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co E10 Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.57 1.49 1.26 1.30 1.16

Mochida Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.30 1.22 1.21 1.12 1.16

FRA:MFY vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's Shiller PE Ratio falls into.


FRA:MFY
71GF Score
Mochida Pharmaceutical Co Ltd FRA:MFY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mochida Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.24/112.7000*112.7000
=0.240

Current CPI (Mar. 2026) = 112.7000.

Mochida Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.697 98.100 0.801
201609 0.504 98.000 0.580
201612 0.871 98.400 0.998
201703 -0.265 98.100 -0.304
201706 0.873 98.500 0.999
201709 0.306 98.800 0.349
201712 0.631 99.400 0.715
201803 -0.048 99.200 -0.055
201806 1.145 99.200 1.301
201809 0.210 99.900 0.237
201812 0.575 99.700 0.650
201903 -0.287 99.700 -0.324
201906 0.690 99.800 0.779
201909 0.277 100.100 0.312
201912 0.377 100.500 0.423
202003 -0.386 100.300 -0.434
202006 0.717 99.900 0.809
202009 0.424 99.900 0.478
202012 0.614 99.300 0.697
202103 0.036 99.900 0.041
202106 0.523 99.500 0.592
202109 0.456 100.100 0.513
202112 1.071 100.100 1.206
202203 0.079 101.100 0.088
202206 0.593 101.800 0.656
202209 0.145 103.100 0.159
202212 0.783 104.100 0.848
202303 -0.274 104.400 -0.296
202306 0.302 105.200 0.324
202309 0.204 106.200 0.216
202312 0.287 106.800 0.303
202403 0.018 107.200 0.019
202406 0.258 108.200 0.269
202409 0.226 108.900 0.234
202412 0.487 110.700 0.496
202503 0.014 111.100 0.014
202506 0.321 111.700 0.324
202509 0.319 112.000 0.321
202512 0.384 113.000 0.383
202603 0.240 112.700 0.240

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €1.16 mean?
Mochida Pharmaceutical Co (FRA:MFY) has a E10 of €1.16 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mochida Pharmaceutical Co and its competitors.
Is Mochida Pharmaceutical Co's E10 too high?
Mochida Pharmaceutical Co's current E10 is €1.16. Overall, Mochida Pharmaceutical Co has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's E10 compare to ZTS and UTHR?
Mochida Pharmaceutical Co's E10 of €1.16 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mochida Pharmaceutical Co and its competitors. Mochida Pharmaceutical Co's current E10 is €1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Mochida Pharmaceutical Co (FRA:MFY) has a current E10 of €1.16. The stock's GF Value™ is €19.68, compared to a current price of €16.70 — trading 15.1% below its estimated fair value. The current E10 is €1.16. Mochida Pharmaceutical Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Mochida Pharmaceutical Co (FRA:MFY), the current E10 is €1.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mochida Pharmaceutical Co (FRA:MFY) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of €16.70 is trading 15.1% below its estimated GF Value™ of €19.68.

Key valuation signals for FRA:MFY:

  • E10: €1.16
  • GF Value™: €19.68 vs. price of €16.70 (15.1% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the FRA:MFY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mochida Pharmaceutical Co Business Description

Other Exchanges 4534:Japan
Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
71GF Score

Get the complete analysis for FRA:MFY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.70
Price
€19.68
GF Value